The Safety and Tolerability of STSA-1002 Following Intravenous Infusion in Healthy Subjects
Clinical trial NCT05032144 · COMPLETED
Trial details
- NCT number
- NCT05032144
- Sponsor
- Staidson (Beijing) Biopharmaceuticals Co., Ltd
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2021-09-28
- Primary completion
- 2022-03-31
- Enrollment
- 40
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.